Magic circle trio Freshfields Bruckhaus Deringer, Linklaters and Slaughter and May have snared the top roles on a joint venture agreement between pharmaceutical giants Novartis and GlaxoSmithKline
April 22, 2014 at 07:52 AM
1 minute read
The original version of this story was published on Legalweek
Magic circle trio Freshfields Bruckhaus Deringer, Linklaters and Slaughter and May have snared the top roles on a joint venture agreement between pharmaceutical giants Novartis and GlaxoSmithKline (GSK).
The transformative deal will involve the two businesses combining their consumer healthcare units in a joint venture with revenues of £6.5bn. Novartis will also acquire GSK’s oncology business for $16bn (£9.5bn) and sell its vaccines division, excluding the flu unit, to GSK for $7.1bn (£4.2bn).
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
